International Mito Patients (IMP): Difference between revisions

From Bioblast
No edit summary
No edit summary
Β 
(4 intermediate revisions by 2 users not shown)
Line 8: Line 8:
}}
}}
Β  Β 
Β  Β 
==Chairman==
Β 
::::Elja van der Veer (The Netherlands)
==Contact details==
Β 
===Chairman===
::::'''Elja van der Veer''' (The Netherlands)
::::Main responsibility: general management, project harmful drugs for mito’s
::::Main responsibility: general management, project harmful drugs for mito’s


==Business address==
===Business address===
::::International Mito Patients
::::International Mito Patients
::::Burg. Uilkensstraat 21
::::Burg. Uilkensstraat 21
::::2861 AD Bergambacht - The Netherlands
::::2861 AD Bergambacht - The Netherlands
Β 
[[Image:MitoGlobal.jpg|right|120px|link=http://www.bioblast.at/index.php/Mitochondrial_Global_Network|MitoGlobal]]
{{MitoGlobal_Societies}}

Latest revision as of 10:40, 11 April 2017


high-resolution terminology - matching measurements at high-resolution


International Mito Patients (IMP)

Description

IMP LOGO.JPGThe International Mito Patients is a network of national patient organizations involved in mitochondrial disease. Mitochondrial disease is a rare disease with a limited number of patients per country. The national patient organizations which are a member of IMP each are active and powerful in their own countries. By joining forces IMP can represent a large group of patients and as such be their voice on an international level.

Abbreviation: IMP

Reference: MitoPatients


MitoPedia topics: MitoGlobal Organizations 


Contact details

Chairman

Elja van der Veer (The Netherlands)
Main responsibility: general management, project harmful drugs for mito’s
E-Mail: [email protected]

Business address

International Mito Patients
Burg. Uilkensstraat 21
2861 AD Bergambacht - The Netherlands
E-mail: [email protected]
MitoGlobal

Listed as a MitoGlobal Society.

MitoGlobal         MitoEAGLE         MitoGlobal Societies         MiPsociety         ASMRM         MitoGlobal Events         MitoGlobal first


Cookies help us deliver our services. By using our services, you agree to our use of cookies.